The British Pharmacological Society conference commenced with the GC Clark symposium on cannabinoids (CBs), an area that was often represented during the general pharmacology sessions of the conference. Endocannabinoids were identified as playing important physiological roles and the CB receptors appear to offer novel therapeutic targets in a range of clinical conditions. This report concentrates on the CB aspects of the meeting.